Compare European CDMOs with EMA-compliant facilities across Germany, Switzerland, Ireland, and the broader EU. Filter by specialization, scale, and regulatory approvals.
926 companies listed
Europe is the second-largest pharma manufacturing region globally, with particular strengths in biologics, API synthesis, and sterile manufacturing. Germany leads in both volume and technological capability, followed by Switzerland (home to major CDMO headquarters), Ireland (a biologics manufacturing hub driven by favorable tax policy), and Italy (strong in API and generics).
EMA regulation provides mutual recognition advantages. A GMP certificate from one EU member state is recognized across the bloc, simplifying multi-market filings. The EMA also maintains Mutual Recognition Agreements (MRAs) with regulators in the US, Canada, Australia, Japan, and other markets, meaning European GMP inspections are often accepted by foreign authorities.
How does pricing compare? European CDMOs typically cost 10-30% more than Asian alternatives but offer shorter lead times for European and US sponsors, stronger IP protection, and established regulatory relationships. For high-value biologics and specialty products, the total cost of quality often favors European manufacturing.
Every country below has its own page with a ranked CDMO list, a country-zoomed facilities map, and the local regulatory picture. Counts are live manufacturing-site totals.
Germany
SIRION Biotech, now part of Revvity (acquired), was a German company founded in 2005 specializing in viral vector development and manufacturing for cell and gene therapy research and preclinical development. Their expertise includes adeno-associated viruses (AAV), lentiviruses, and adenoviruses, plus the LentiBOOST transduction enhancer technology. However, SIRION Biotech's services are now fully integrated into Revvity's gene delivery division. They serve biotech and pharma companies with viral vector R&D services and preclinical-stage manufacturing, not as an independent CDMO offering clinical/commercial GMP manufacturing under contract. Their work is research-services focused.
Poland
S-LAB Sp. z o.o. is a Polish pharmaceutical company that develops and manufactures its own branded products including prescription drugs (OTC and Rx), medical devices, cosmetics, and dietary supplements. Their focus areas include ophthalmology (eye drops) and cold remedies. They have their own development department, laboratories, and production facilities. While they have manufacturing capabilities, they are a branded pharmaceutical company producing their own products, not a contract manufacturer providing CDMO/CMO services to other companies.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
Italy
Sochim International S.p.A. is an Italian CDMO specializing in nutraceuticals and dietary supplements, now part of the Naturacare group. The company manufactures softgels, capsules, tablets, powders, and liquids for the nutritional/supplement market. While it uses CDMO terminology, its focus is on dietary supplements, not pharmaceutical drugs.
